40 results on '"Kong, Ranran"'
Search Results
2. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade
- Author
-
Ma, Zhenchuan, Ma, Yuefeng, Feng, Jie, Xu, Zhengshui, Cheng, Chuantao, Qin, Jie, Li, Shaomin, Jiang, Jiantao, and Kong, Ranran
- Published
- 2024
- Full Text
- View/download PDF
3. CFD-DEM investigation of the flow characteristic of biomass particles and heat carrier in a novel V-shaped down-tube pyrolysis reactor
- Author
-
Bi, Dongmei, Kong, Ranran, Liu, Shanjian, He, Jianjie, Sun, Haiquan, and Yao, Di
- Published
- 2023
- Full Text
- View/download PDF
4. Preparation of fluorescent UV-curable adhesives containing AIEgen-modified monomer
- Author
-
Deng, Jingyu, Kong, Ranran, Liu, Zhiping, Weng, Yuchen, and Fan, Li-Juan
- Published
- 2023
- Full Text
- View/download PDF
5. Strongly fluorescent conjugated polymer nanoparticles in aqueous colloidal solution for universal, efficient and effective development of sebaceous and blood fingerprints
- Author
-
Fan, Zhinan, Chen, Xiao, Kong, Ranran, Lu, Yaoqi, Ma, Rongliang, Wu, Jia-Wei, and Fan, Li-Juan
- Published
- 2023
- Full Text
- View/download PDF
6. Hsa-miR-1269a up-regulation fosters the malignant progression of esophageal squamous cell carcinoma via targeting FAM46C
- Author
-
Ma, Yuefeng, Xing, Xin, Cheng, Chuantao, Kong, Ranran, Sun, Liangzhang, Zhao, Feng, Zhang, Danjie, and Li, Jianzhong
- Published
- 2023
- Full Text
- View/download PDF
7. Co-pyrolysis of chitin with nitrogen carriers: Kinetics, product characterization and bio-oil analysis
- Author
-
Liu, Jia, Liu, Shanjian, Zhao, An, Bi, Dongmei, Yao, Di, and Kong, Ranran
- Published
- 2023
- Full Text
- View/download PDF
8. Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection
- Author
-
Liu, Shuhui, Zhao, Kaitao, Su, Xi, Gao, Xiaoxiao, Yao, Yongxuan, Kong, Ranran, Wang, Yun, Wu, Chunchen, Lu, Mengji, Chen, Xinwen, and Pei, Rongjuan
- Published
- 2022
- Full Text
- View/download PDF
9. Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression
- Author
-
Yoo, Seungyeul, Sinha, Abhilasha, Yang, Dawei, Altorki, Nasser K., Tandon, Radhika, Wang, Wenhui, Chavez, Deebly, Lee, Eunjee, Patel, Ayushi S., Sato, Takashi, Kong, Ranran, Ding, Bisen, Schadt, Eric E., Watanabe, Hideo, Massion, Pierre P., Borczuk, Alain C., Zhu, Jun, and Powell, Charles A.
- Published
- 2022
- Full Text
- View/download PDF
10. A Universal Developing Strategy for Fingermark Detection and Enhancement Based on Disodium Iminodiacetate-Functionalized Conjugated Polymer.
- Author
-
Kong, Ranran, Cao, Sicheng, Zhang, Jincheng, Ma, Rongliang, and Fan, Li-Juan
- Published
- 2024
- Full Text
- View/download PDF
11. MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling
- Author
-
Fan, Na, Zhang, Jin, Cheng, Chuantao, Zhang, Xinwu, Feng, Jie, and Kong, Ranran
- Published
- 2017
- Full Text
- View/download PDF
12. Inhibition of microRNA-429 attenuates oxygen–glucose deprivation/reoxygenation-induced neuronal injury by promoting expression of GATA-binding protein 4
- Author
-
Xiao, Jie, Kong, Ranran, and Hu, Jingye
- Published
- 2018
- Full Text
- View/download PDF
13. O-linked N-acetylglucosamine transferase (OGT) is overexpressed and promotes O-linked protein glycosylation in esophageal squamous cell carcinoma
- Author
-
Qiao, Zhe, Dang, Chengxue, Zhou, Bin, Li, Shaomin, Zhang, Wei, Jiang, Jiantao, Zhang, Jin, Kong, Ranran, and Ma, Yuefeng
- Published
- 2012
- Full Text
- View/download PDF
14. Integrative genomic and epigenomic analyses identify a distinct role of c-Myc and L-Myc for lineage determination in small cell lung cancer
- Author
-
Patel, Ayushi S., Yoo, Seungyeul, Kong, Ranran, Sato, Takashi, Fridrikh, Maya, Sinha, Abhilasha, Nudelman, German, Powell, Charles A., Beasley, Mary Beth, Zhu, Jun, and Watanabe, Hideo
- Subjects
respiratory tract diseases - Abstract
Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer that has a dismal prognosis. Patients with SCLC are uniformly treated with chemotherapy plus radiotherapy and recently with immunotherapy; however, emerging molecular evidence suggests this disease represents heterogeneous groups. At the genomic level, in addition to the near universal loss of p53 and Rb1, the loci for all three Myc family members are frequently amplified in a mutually exclusive manner, suggesting their redundant oncogenic function. However, the expression of these factors is associated with specific neuroendocrine markers and distinct histopathology, and yet the contribution of Myc family members to SCLC molecular subtypes have not been clearly delineated. In this study, we explored a novel role of c-Myc and L-Myc as lineage specific factors contributing to SCLC molecular subtypes and histological classification. Integrated analyses of a Bayesian network generated from primary tumor mRNA expression and chromatin state profiling of SCLC cell lines showed that Myc family members impart distinct transcriptional programs associated with lineage state; wherein L-Myc was enriched for neuronal pathways and c-Myc for Notch signaling and epithelial-to-mesenchymal transition. We investigated the functional redundancy of c-Myc and L-Myc, and noted the insufficiency of L-Myc to induce lineage switch in contrast to the potential of c-Myc to induce trans-differentiation from ASCL1-SCLC to a NeuroD1-SCLC characterized by distinct histopathology. Collectively, our findings reveal a previously undescribed role for historically defined general oncogenes, c-Myc and L-Myc, in regulating lineage plasticity across molecular subtypes as well as histological classes.
- Published
- 2019
- Full Text
- View/download PDF
15. Study of the performance of nitrogen-doped modified activated carbon as catalyst carrier for the selective catalytic reduction of NO with NH3 at low temperatures.
- Author
-
Feng, Xiangdong, Liu, Shanjian, Li, Yongjun, Kong, Ranran, and He, Jianjie
- Abstract
Nitrogen-doped modified activated carbons (ACs) were prepared from coconut shell, date shell and almond shell using the urea modification method. NO tests of NH
3 selective catalytic reduction (NH3 -SCR) were conducted to evaluate the efficiency of different types of nitrogen-doped modified AC as denitration catalyst carriers between 50–220°C. Both AC and nitrogen-doped modified AC had catalytic effects on NO conversion; the nitrogen-doped modified AC had high denitrification activity in the low-temperature region, and NAC1 -10 achieved an NO conversion rate of 65.7% at 50°C. The low-temperature denitrification activity of urea-modified AC was twice that of the untreated AC at all temperatures. The O2 concentration in the SCR reaction system had a significant effect on the NO conversion rate of the nitrogen-doped modified AC. As the O2 concentration increased from 0 to 1 vol%, the NO conversion rate increased rapidly from 22 to 65% and remained stable at 65%. A series of characterisation tools were used to determine the structure and physicochemical properties of the nitrogen-doped modified AC, including BET, XRD, elemental analysis, and FTIR. Nitrogen-doped AC showed good air velocity adaptability and low-temperature stability, suggesting that it is a promising carrier for NH3 -SCR catalysts. Nitrogen-doped modified activated carbons (NACs) were prepared from coconut shell, date shell, and almond shell using the urea modification method. NO tests of NH3 selective catalytic reduction (NH3 -SCR) were conducted to evaluate the efficiency of different types of nitrogen-doped modified AC as denitration catalyst carriers at 50–220°C. NACs denitrification activity tests were carried out in a fixed-bed reactor with an inner diameter of 15 mm and a total gas flow rate of 500 mL·min−1 flue gas. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. SphK1 promotes development of non-small cell lung cancer through activation of STAT3.
- Author
-
Ma, Yuefeng, Xing, Xin, Kong, Ranran, Cheng, Chuantao, Li, Suoni, Yang, Xiaoping, Li, Shaomin, Zhao, Feng, Sun, Liangzhang, and Cao, Gang
- Published
- 2021
17. Clemaichinenoside protects renal tubular epithelial cells from hypoxia/reoxygenation injury in vitro through activating the Nrf2/HO‐1 signalling pathway.
- Author
-
Feng, Jie, Kong, Ranran, Xie, Liyi, Lu, Wanhong, Zhang, Yali, Dong, Hongjuan, and Jiang, Hongli
- Subjects
- *
EPITHELIAL cells , *ANDROGEN receptors , *ACUTE kidney failure , *HYPOXEMIA , *SUPEROXIDE dismutase , *WOUNDS & injuries , *PLANT growth - Abstract
Renal ischaemia/reperfusion (I/R) is a major cause of acute renal failure with increased morbidity, mortality, and prolonged hospitalizations. Clematichinenoside (AR), a triterpenoid saponin isolated from the roots of Clematis chinensis, was reported to possess a protective effect against I/R injury. However, the effect of AR on renal I/R injury has not been evaluated. This study aims to examine the effect of AR on an in vitro I/R model in human proximal tubular epithelial cells HK‐2. HK‐2 cells were subjected to hypoxia/reoxygenation (H/R) stimulation to mimic I/R in vitro. The results showed that AR improved cell viability of H/R‐stimulated HK‐2 cells. AR pretreatment resulted in decreased production of reactive oxygen species (ROS) and malondialdehyde (MDA), as well as increased in superoxide dismutase (SOD) activity in H/R‐stimulated HK‐2 cells. In addition, AR also presented an anti‐inflammatory activity, as evidenced by decreased secretion of pro‐inflammatory cytokines including IL‐6, IL‐1β, and TNF‐α. Moreover, apoptotic rate was markedly decreased in HK‐2 cells pretreated with AR. The bax expression was decreased, while bcl‐2 expression was increased by AR pretreatment. Furthermore, AR enhanced the H/R‐stimulated activation of the Nrf2/HO‐1 signalling pathway in HK‐2 cells. In conclusion, these findings indicated that AR protected HK‐2 cells from H/R‐induced cell injury via regulating the Nrf2/HO‐1 signalling pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. MicroRNA‐1271 suppresses the proliferation and invasion of colorectal cancer cells by regulating metadherin/Wnt signaling.
- Author
-
Sun, Xiaoli, Zhai, Hongjun, Chen, Xi, Kong, Ranran, and Zhang, Xinwu
- Abstract
Abstract: Recent studies have reported an important role for microRNA‐1271 (miR‐1271) in tumorigenesis. However, the role of miR‐1271 in colorectal cancer remains unknown. Here, we found that miR‐1271 was significantly decreased in colorectal cancer tissues and cell lines. Overexpression of miR‐1271 inhibited cell proliferation, colony formation, cell invasion, and induced cell cycle arrest in colorectal cancer cells. Metadherin (MTDH) was identified as a target gene of miR‐1271. Moreover, miR‐1271 negatively regulated MTDH expression in colorectal cancer cells and reversely correlated with MTDH expression in colorectal cancer specimens. Additionally, miR‐1271 also regulated the activation of Wnt signaling in colorectal cancer cells. The restoration of MTDH expression significantly reversed the antitumor effect of miR‐1271 in colorectal cancer cells. These findings indicate an important role for miR‐1271/MTDH in the tumorigenesis of colorectal cancer, and suggest that miR‐1271 may be a novel therapeutic target for colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
- Author
-
Zhang, Jin, Kong, Ranran, and Sun, Liangzhang
- Subjects
- *
RAS proteins , *SQUAMOUS cell carcinoma , *ESOPHAGEAL cancer , *GENE silencing , *CANCER cell proliferation , *CARCINOGENESIS , *GENETICS - Abstract
Rab3D is a member of the ras-related GTP-binding protein Rab family and was found up-regulated in several types of cancer. However, little is known about the role of Rab3D in carcinogenesis and progression of esophageal squamous cell carcinoma (ESCC). Thus, in this study, we investigated the expression patterns and functional roles of Rab3D in human ESCC. We demonstrated that Rab3D was highly expressed in human ESCC cell lines. In addition, knockdown of Rab3D significantly inhibited the proliferation of ESCC cells and reduced the tumorigenesis in vivo . Moreover, knockdown of Rab3D significantly suppressed ESCC cell migration/invasion and accordingly alerted EMT related markers, which including up-regulated E-cadherin and down-regulated N-cadherin in ESCC cells. Finally, knockdown of Rab3D inhibited the levels of p-PI3K and p-Akt in ECA-109 cells. In conclusion, our data demonstrated that Rab3D functions as an oncogene in ESCC and knockdown of Rab3D suppressed ESCC cell proliferation and invasion, potentially through the PI3K/Akt signaling pathway. Overall, these findings suggest that targeting the Rab3D may be a potential therapeutic target for treatment of ESCC. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
20. Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion.
- Author
-
Shao, Hongwei, Kong, Ranran, Ferrari, Massimiliano L., Radtke, Freddy, Capobianco, Anthony J., and Liu, Zhao-Jun
- Subjects
- *
NOTCH genes , *FIBROBLASTS , *MELANOMA treatment , *CANCER cell growth , *CANCER invasiveness , *LABORATORY mice - Abstract
Cancer-associated fibroblasts (CAF) play a crucial role in regulating cancer progression, yet the molecular determinant that governs the tumor regulatory role of CAF remains unknown. Using a mouse melanoma model in which exogenous melanoma cells were grafted on the skin of two lines of mice where the genetic activation or inactivation of Notch1 signaling specifically occurs in natural host stromal fibroblasts, we demonstrated that Notch1 pathway activity could determine the tumor-promoting or tumor-suppressing phenotype in CAF. CAF carrying elevated Notch1 activity significantly inhibited melanoma growth and invasion, while those with a null Notch1 promoted melanoma invasion. These findings identify the Notch1 pathway as a molecular determinant that controls the regulatory role of CAF in melanoma skin growth and invasion, unveiling Notch1 signaling as a potential therapeutic target for melanoma and potentially other solid tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. The effectiveness of alprostadil in treating coronary microcirculation dysfunction following ST-segment elevation myocardial infarction in a pig model.
- Author
-
Duan, Tianbing, Zhang, Jinxia, Kong, Ranran, Song, Rui, Huang, Weilong, and Xiang, Dingcheng
- Subjects
ST elevation myocardial infarction ,PROSTAGLANDIN E1 ,PULMONARY arterial hypertension ,MICROCIRCULATION ,VENTRICULAR ejection fraction - Abstract
Though alprostadil has been reported to improve the impaired microcirculation of patients with pulmonary arterial hypertension, its effectiveness as a treatment for coronary microvasculature dysfunction (CMD) following ST-segment elevation myocardial infarction (STEMI) is unknown. A total of 18 miniature pigs with CMD following STEMI were randomized into three groups that received an intracoronary injection of 5 ml of normal saline, 2 mg of nicorandil or 10 µg of alprostadil immediately after measurement of the index of microcirculatory resistance (IMR) and then an intravenous drip containing 5 ml of normal saline, 2 mg of nicorandil or 10 µg of alprostadil once a day for 6 days. The IMR, cardiac function using ultrasound, infarct areas and heparanase levels in infarct areas were measured and compared between the three groups. The IMR decreased markedly 10 min after alprostadil or nicorandil intracoronary injection (both P<0.05) but not following saline injection (P>0.05). After 7 days, the IMR was substantially lower in the alprostadil and nicorandil groups compared with the saline group (both P<0.05) and the ejection fraction was considerably higher in the alprostadil and nicorandil groups compared with the saline group (both P<0.05). Differences in infarct areas and the relative heparanase expression levels among the 3 groups were similar to the differences in the ejection fraction. No significant differences in the above assessment indexes were identified in the alprostadil and nicorandil groups. Alprostadil infusion improved coronary microcirculation function, reduced the infarct area and limited left ventricular dilatation in a pig coronary microvasculature dysfunction model following STEMI. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Influence of Fuel Type and Water Content Variation on Pollutant Emission Characteristics of a Biomass Circulating Fluidized Bed Boiler.
- Author
-
He, Jianjie, Liu, Shanjian, Yao, Di, Kong, Ranran, and Liu, Yaya
- Subjects
POLLUTANTS ,BIOMASS burning ,BIOMASS ,COMBUSTION gases ,RAW materials - Abstract
In general, the biomass raw materials burned by biomass power plants generally have the characteristics of variable fuel types, high moisture content, and high volatile content. In this paper, a 130 t/h biomass circulating fluidized bed (BCFB) model was established on the MWorks platform with Modelica language. The influence of biomass type changes on operation parameters, the corresponding steady-state characteristics, and the dynamic characteristics of the BCFB were carried out. The temperature corresponding to the combustion of pine was overall higher than that of the other fuels, and the flue gas from the combustion of pine had the highest concentration of SO
2 , up to 520.49 mg/Nm3 . The flue gas from the combustion of pure cotton sticks had the highest concentration of NO, up to 254.34 mg/Nm3 . The changes of fuel type and moisture content all have a great influence on the operation of BCFBs. The emission of pollutants was not only related to the element content of fuel, but also closely related to the furnace temperature. The fuel moisture content also indirectly affects the pollutant emission concentration and the steam-water system. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
23. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
- Author
-
Feng, Jie, Xie, Liyi, Yu, Xiaoyang, Liu, Chao, Dong, Hongjuan, Lu, Wanhong, and Kong, Ranran
- Subjects
- *
PERILIPIN , *OXIDATIVE stress , *DIABETIC nephropathies , *DIABETES complications , *APOPTOSIS , *HYPERGLYCEMIA , *GLYCOGEN synthase kinase-3 - Abstract
Hyperglycemia-induced podocyte damage contributes to the onset of diabetic nephropathy, a severe complication of diabetes. Perilipin 5 (Plin5) exerts a vital role in numerous pathological conditions via affecting cell apoptosis, oxidative stress, and inflammation. However, whether Plin5 plays a role in regulating podocyte damage of diabetic nephropathy has not been fully determined. This work aimed to explore the role of Plin5 in mediating high glucose (HG)-induced injury of podocytes in vitro. Our results demonstrated that Plin5 expression was markedly decreased in mouse podocytes challenged with HG. Plin5 overexpression markedly suppressed HG-induced apoptosis, reactive oxygen species (ROS) production, and the pro-inflammatory response in podocytes. On the contrary, Plin5 silencing produced the opposite effects. Further mechanistic analysis demonstrated that Plin5 upregulation remarkably increased the levels of phospho-Akt and phospho-glycogen synthase kinase-3β (GSK-3β) in HG-exposed podocytes. Moreover, Plin5 overexpression increased the levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and enhanced the activation of Nrf2 signaling. Akt inhibition markedly blocked Plin5-mediated activation of Nrf2, while GSK-3β inhibition reversed Plin5-silencing-induced suppressive effects on Nrf2 activation. Notably, Nrf2 suppression significantly blocked Plin5-mediated protective effects against HG-induced podocyte injury. In summary, our work indicates a vital role for Plin5 in protecting against HG-induced apoptosis, oxidative stress, and inflammation in podocytes via modulation of Akt/GSK-3β/Nrf2 signaling. This study suggests that Plin5 may participate in modulating podocyte damage in diabetic nephropathy. Image 1 • Plin5 protected from HG-induced podocyte injury. • Plin5 potentiated Nrf2 signaling in HG-exposed podocytes. • Plin5 regulated Nrf2 activation by Akt/GSK-3β. • Plin5 ameliorated HG-induced podocyte injury by Nrf2. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis.
- Author
-
Feng J, Xie L, Lu W, Yu X, Dong H, Ma Y, and Kong R
- Subjects
- Animals, Mice, Disease Models, Animal, Humans, Male, Podocytes metabolism, Podocytes pathology, CDC2 Protein Kinase metabolism, Tumor Suppressor Protein p53 metabolism, Protein-Tyrosine Kinases metabolism, Protein-Tyrosine Kinases antagonists & inhibitors, Doxorubicin pharmacology, Cyclin B1 metabolism, Cell Cycle Proteins metabolism, Mitosis
- Abstract
Podocyte loss in glomeruli is a fundamental event in the pathogenesis of chronic kidney diseases. Currently, mitotic catastrophe (MC) has emerged as the main cause of podocyte loss. However, the regulation of MC in podocytes has yet to be elucidated. The current work aimed to study the role and mechanism of p53 in regulating the MC of podocytes using adriamycin (ADR)-induced nephropathy. In vitro podocyte stimulation with ADR triggered the occurrence of MC, which was accompanied by hyperactivation of p53 and cyclin-dependent kinase (CDK1)/cyclin B1. The inhibition of p53 reversed ADR-evoked MC in podocytes and protected against podocyte injury and loss. Further investigation showed that p53 mediated the activation of CDK1/cyclin B1 by regulating the expression of Wee1. Restraining Wee1 abolished the regulatory effect of p53 inhibition on CDK1/cyclin B1 and rebooted MC in ADR-stimulated podocytes via p53 inhibition. In a mouse model of ADR nephropathy, the inhibition of p53 ameliorated proteinuria and podocyte injury. Moreover, the inhibition of p53 blocked the progression of MC in podocytes in ADR nephropathy mice through the regulation of the Wee1/CDK1/cyclin B1 axis. Our findings confirm that p53 contributes to MC in podocytes through regulation of the Wee1/CDK1/Cyclin B1 axis, which may represent a novel mechanism underlying podocyte injury and loss during the progression of chronic kidney disorder.
- Published
- 2024
- Full Text
- View/download PDF
25. A novel mitochondrial metabolism-related gene signature for predicting the prognosis of oesophageal squamous cell carcinoma.
- Author
-
Lin W, Ye C, Sun L, Chen Z, Qu C, Zhu M, Li J, Kong R, and Xu Z
- Subjects
- Humans, Prognosis, Male, Female, Gene Expression Regulation, Neoplastic, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Middle Aged, Transcriptome, Gene Expression Profiling, Esophageal Squamous Cell Carcinoma genetics, Esophageal Squamous Cell Carcinoma mortality, Esophageal Squamous Cell Carcinoma pathology, Esophageal Squamous Cell Carcinoma metabolism, Esophageal Neoplasms genetics, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Esophageal Neoplasms metabolism, Mitochondria genetics, Mitochondria metabolism, Nomograms
- Abstract
Oesophageal squamous cell carcinoma (ESCC) is one of the most lethal cancers worldwide. Due to the important role of mitochondrial metabolism in cancer progression, a clinical prognostic model based on mitochondrial metabolism and clinical features was constructed in this study to predict the prognosis of ESCC. Firstly, the mitochondrial metabolism scores (MMs) were calculated based on 152 mitochondrial metabolism-related genes (MMRGs) by single sample gene set enrichment analysis (ssGSEA). Subsequently, univariate Cox regression and LASSO algorithm were used to identify prognosis-associated MMRG and risk-stratify patients. Functional enrichment, interaction network and immune-related analyses were performed to explore the features differences in patients at different risks. Finally, a prognostic nomogram incorporating clinical factors was constructed to assess the prognosis of ESCC. Our results found there were differences in clinical features between the MMs-high group and the MMs-low group in the TCGA-ESCC dataset ( P <0.05). Afterwards, we identified 6 MMRGs (COX10, ACADVL, IDH3B, AKR1A1, LIAS, and NDUFB8) signature that could accurately distinguish high-risk and low-risk ESCC patients. A predictive nomogram that combined the 6 MMRGs with sex and N stage to predict the prognosis of ESCC was constructed, and the areas under the receiver operating characteristic (ROC) curve at 1, 2 and 3 years were 0.948, 0.927 and 0.848, respectively. Finally, we found that COX10, one of 6 MMRGs, could inhibit the malignant progression of ESCC in vitro . In summary, we constructed a clinical prognosis model based on 6 MMRGs and clinical features which can accurately predict the prognosis of ESCC patients.
- Published
- 2024
- Full Text
- View/download PDF
26. Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung Cancer.
- Author
-
Kong R, Patel AS, Sato T, Jiang F, Yoo S, Bao L, Sinha A, Tian Y, Fridrikh M, Liu S, Feng J, He X, Jiang J, Ma Y, Grullon K, Yang D, Powell CA, Beasley MB, Zhu J, Snyder EL, Li S, and Watanabe H
- Subjects
- Animals, Humans, Mice, Cell Transformation, Neoplastic, Lung, Transcription Factors genetics, Transcription Factors metabolism, Lung Neoplasms pathology, Small Cell Lung Carcinoma genetics, Small Cell Lung Carcinoma pathology, SOXB1 Transcription Factors genetics, Thyroid Nuclear Factor 1 genetics
- Abstract
Rationale: The current molecular classification of small-cell lung cancer (SCLC) on the basis of the expression of four lineage transcription factors still leaves its major subtype SCLC-A as a heterogeneous group, necessitating more precise characterization of lineage subclasses. Objectives: To refine the current SCLC classification with epigenomic profiles and to identify features of the redefined SCLC subtypes. Methods: We performed unsupervised clustering of epigenomic profiles on 25 SCLC cell lines. Functional significance of NKX2-1 (NK2 homeobox 1) was evaluated by cell growth, apoptosis, and xenograft using clustered regularly interspaced short palindromic repeats-Cas9 (CRISPR-associated protein 9)-mediated deletion. NKX2-1-specific cistromic profiles were determined using chromatin immunoprecipitation followed by sequencing, and its functional transcriptional partners were determined using coimmunoprecipitation followed by mass spectrometry. Rb1
flox/flox ; Trp53flox/flox and Rb1flox/flox ; Trp53flox/flox ; Nkx2-1flox/flox mouse models were engineered to explore the function of Nkx2-1 in SCLC tumorigenesis. Epigenomic landscapes of six human SCLC specimens and 20 tumors from two mouse models were characterized. Measurements and Main Results: We identified two epigenomic subclusters of the major SCLC-A subtype: SCLC-Aα and SCLC-Aσ. SCLC-Aα was characterized by the presence of a super-enhancer at the NKX2-1 locus, which was observed in human SCLC specimens and a murine SCLC model. We found that NKX2-1, a dual lung and neural lineage factor, is uniquely relevant in SCLC-Aα. In addition, we found that maintenance of this neural identity in SCLC-Aα is mediated by collaborative transcriptional activity with another neuronal transcriptional factor, SOX1 (SRY-box transcription factor 1). Conclusions: We comprehensively describe additional epigenomic heterogeneity of the major SCLC-A subtype and define the SCLC-Aα subtype by the core regulatory circuitry of NKX2-1 and SOX1 super-enhancers and their functional collaborations to maintain neuronal linage state.- Published
- 2022
- Full Text
- View/download PDF
27. Exercise training combined with alprostadil improves myocardial infarction and coronary microcirculation disorder in aged rats by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway activation.
- Author
-
Zhang J, Long F, Duan T, Li A, Kong R, Zhu Y, and Xiang D
- Abstract
Background: We aimed to explore the effects and mechanisms of exercise training combined with alprostadil (ALPR) treatment on myocardial infarction (MI) in aged rats., Methods: Male Wistar rats were randomly divided into five groups. One day after MI induction, an automatic biochemical analyzer was used to measure cardiac troponin I (cTnI), cardiac troponin T (cTnT), and creatine kinase MB isoenzyme (CK-MB) serum levels. One week after MI induction, echocardiography was performed to examine the left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular ejection fraction (LVEF), and left ventricular fraction shortening (LVFS) rates of the rats. Parameters such as body weight (BW), heart mass index, and the heart weight (HW)/tibia length (TL) ratio of the rats were also calculated. Western blot was performed to assess angiogenesis and mitogen-activated protein kinase (MAPK) signal-related protein expression., Results: Compared with the MI group, the LVEDD and LVESD in the Trained + ALPR group were significantly decreased, while LVEF, LVFS, HW/BW, and HW/TL were significantly increased. Additionally, the Trained + ALPR group exhibited decreased levels of cTnI, cTnT, and CK-MB and significantly reduced MI size and myocardial injury. Moreover, compared with the Trained or ALPR group, the Trained + ALPR group showed upregulated energy metabolism, increased microvessel density, and better efficacy. Finally, the Trained + ALPR group showed a significant increase in angiogenesis-related proteins and a significant reduction in MAPK signaling pathway-related protein activity., Conclusions: Exercise training combined with ALPR improved MI in elderly rats by inhibiting MAPK signaling, promoting angiogenesis, and increasing metabolism., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-5763/coif). The authors have no conflicts of interest to declare., (2022 Annals of Translational Medicine. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
28. Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.
- Author
-
Sinha A, Zou Y, Patel AS, Yoo S, Jiang F, Sato T, Kong R, Watanabe H, Zhu J, Massion PP, Borczuk AC, and Powell CA
- Abstract
Lung cancer is the most common cause of cancer-related deaths in both men and women, accounting for one-quarter of total cancer-related mortality globally. Lung adenocarcinoma is the major subtype of non-small cell lung cancer (NSCLC) and accounts for around 40% of lung cancer cases. Lung adenocarcinoma is a highly heterogeneous disease and patients often display variable histopathological morphology, genetic alterations, and genomic aberrations. Recent advances in transcriptomic and genetic profiling of lung adenocarcinoma by investigators, including our group, has provided better stratification of this heterogeneous disease, which can facilitate devising better treatment strategies suitable for targeted patient cohorts. In a recent study we have shown gene expression profiling identified novel clustering of early stage LUAD patients and correlated with tumor invasiveness and patient survival. In this study, we focused on copy number alterations in LUAD patients. SNP array data identified amplification at chromosome 12q15 on MDM2 locus and protein overexpression in a subclass of LUAD patients with an invasive subtype of the disease. High copy number amplification and protein expression in this subclass correlated with poor overall survival. We hypothesized that MDM2 copy number and overexpression predict response to MDM2-targeted therapy. In vitro functional data on a panel of LUAD cells showed that MDM2-targeted therapy effectively suppresses cell proliferation, migration, and invasion in cells with MDM2 amplification/overexpression but not in cells without MDM2 amplification, independent of p53 status. To determine the key signaling mechanisms, we used RNA sequencing (RNA seq) to examine the response to therapy in MDM2-amplified/overexpressing p53 mutant and wild-type LUAD cells. RNA seq data shows that in MDM2-amplified/overexpression with p53 wild-type condition, the E2F → PEG10 → MMPs pathway is operative, while in p53 mutant genetic background, MDM2-targeted therapy abrogates tumor progression in LUAD cells by suppressing epithelial to mesenchymal transition (EMT) signaling. Our study provides a potentially clinically relevant strategy of selecting LUAD patients for MDM2-targeted therapy that may provide for increased response rates and, thus, better survival.
- Published
- 2022
- Full Text
- View/download PDF
29. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn.
- Author
-
Xu Z, Cheng C, Kong R, Liu Y, Wang S, Ma Y, and Xing X
- Subjects
- Adult, Animals, Cell Proliferation, Disease Models, Animal, Female, Hot Temperature, Humans, Male, Mice, Inbred BALB C, Up-Regulation genetics, Mice, Burns pathology, Calgranulin A metabolism, Calgranulin B metabolism, Cell Movement, Cicatrix pathology, Epithelial-Mesenchymal Transition, Keratinocytes pathology, Proto-Oncogene Proteins metabolism, Trans-Activators metabolism
- Abstract
S100 calcium-binding protein A8 (S100A8) and S100A9 are small molecular weight calcium-binding regulatory proteins that have been involved in multiple chronic inflammatory diseases. However, the role of S100A8 and S100A9 in keratinocytes in wounded skin and how they are regulated during this process are still unclear. Here, we found that S100A8 and S100A9 were both upregulated in burn-wounded skins in vivo and thermal-stimulated epidermal keratinocytes in vitro , accompanied by increased levels of epithelial-mesenchymal transition (EMT). Then, we demonstrated that upregulation of S100A8 and S100A9 alone or together enhanced characteristics of EMT in normal keratinocytes, manifested by excessive proliferation rate, abnormal ability of cell invasion, and high expression levels of EMT marker proteins. The transcription factor PU box-binding protein (PU.1) bound to the promoter regions and transcriptionally promoted the expression of S100A8 and S100A9 both in the human and mice, and it had strong positive correlations with both S100A8 and S100A9 protein levels in burned skin in vivo . Moreover, PU.1 positively regulated expression of S100A8 and S100A9 in a dose-dependent manner, and enhanced EMT of keratinocytes in vitro . Finally, through the burn mouse model, we found that PU.1
-/- mice displayed a lower ability of scar formation, manifested by smaller scar volume, thickness, and collagen content, which could be enhanced by S100A8 and S100A9. In conclusion, PU.1 transcriptionally promotes expression of S100A8 and S100A9, thus positively regulating epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn.- Published
- 2021
- Full Text
- View/download PDF
30. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer.
- Author
-
Patel AS, Yoo S, Kong R, Sato T, Sinha A, Karam S, Bao L, Fridrikh M, Emoto K, Nudelman G, Powell CA, Beasley MB, Zhu J, and Watanabe H
- Subjects
- Humans, Oncogenes, Lung Neoplasms genetics, Lung Neoplasms metabolism, Small Cell Lung Carcinoma genetics, Small Cell Lung Carcinoma metabolism
- Abstract
Comprehensive genomic analyses of small cell lung cancer (SCLC) have revealed frequent mutually exclusive genomic amplification of MYC family members. Hence, it has been long suggested that they are functionally equivalent; however, more recently, their expression has been associated with specific neuroendocrine markers and distinct histopathology. Here, we explored a previously undescribed role of L-Myc and c-Myc as lineage-determining factors contributing to SCLC molecular subtypes and histology. Integrated transcriptomic and epigenomic analyses showed that L-Myc and c-Myc impart neuronal and non-neuroendocrine-associated transcriptional programs, respectively, both associated with distinct SCLC lineage. Genetic replacement of c-Myc with L-Myc in c-Myc-SCLC induced a neuronal state but was insufficient to induce ASCL1-SCLC. In contrast, c-Myc induced transition from ASCL1-SCLC to NEUROD1-SCLC characterized by distinct large-cell neuroendocrine carcinoma-like histopathology. Collectively, we characterize a role of historically defined general oncogenes, c-Myc and L-Myc, for regulating lineage plasticity across molecular and histological subtypes., (Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).)
- Published
- 2021
- Full Text
- View/download PDF
31. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
- Author
-
Sato T, Yoo S, Kong R, Sinha A, Chandramani-Shivalingappa P, Patel A, Fridrikh M, Nagano O, Masuko T, Beasley MB, Powell CA, Zhu J, and Watanabe H
- Subjects
- Aged, Carcinoma, Squamous Cell pathology, Cell Differentiation genetics, Cell Line, Tumor, Chromatin Immunoprecipitation Sequencing, Enhancer Elements, Genetic genetics, Epigenomics, Female, Genetic Heterogeneity, HEK293 Cells, Humans, Lung pathology, Lung Neoplasms pathology, Male, MicroRNAs, Primary Cell Culture, RNA-Seq, Transcription Factors metabolism, Tumor Suppressor Proteins metabolism, Xenograft Model Antitumor Assays, Carcinoma, Squamous Cell genetics, Gene Expression Regulation, Neoplastic, Homeodomain Proteins metabolism, Lung Neoplasms genetics, POU Domain Factors metabolism, SOXB1 Transcription Factors metabolism
- Abstract
Molecular characterization of lung squamous cell carcinoma (LUSC), one of the major subtypes of lung cancer, has not sufficiently improved its nonstratified treatment strategies over decades. Accumulating evidence suggests that lineage-specific transcriptional regulators control differentiation states during cancer evolution and underlie their distinct biological behaviors. In this study, by investigating the super-enhancer landscape of LUSC, we identified a previously undescribed "neural" subtype defined by Sox2 and a neural lineage factor Brn2, as well as the classical LUSC subtype defined by Sox2 and its classical squamous partner p63. Robust protein-protein interaction and genomic cooccupancy of Sox2 and Brn2, in place for p63 in the classical LUSC, indicated their transcriptional cooperation imparting this unique lineage state in the "neural" LUSC. Forced expression of p63 downregulated Brn2 in the "neural" LUSC cells and invoked the classical LUSC lineage with more squamous/epithelial features, which were accompanied by increased activities of ErbB/Akt and MAPK-ERK pathways, suggesting differential dependency. Collectively, our data demonstrate heterogeneous cell lineage states of LUSC featured by Sox2 cooperation with Brn2 or p63, for which distinct therapeutic approaches may be warranted. SIGNIFICANCE: Epigenomic profiling reveals a novel subtype of lung squamous cell carcinoma with neural differentiation. Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/24/6084/F1.large.jpg., (©2019 American Association for Cancer Research.)
- Published
- 2019
- Full Text
- View/download PDF
32. Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
- Author
-
Duan T, Zhang J, Xiang D, Song R, Kong R, and Xu D
- Subjects
- Adenosine Triphosphate pharmacology, Alprostadil pharmacology, Animals, Papaverine pharmacology, Swine, Vasodilator Agents pharmacology, Adenosine Triphosphate administration & dosage, Alprostadil administration & dosage, Coronary Circulation drug effects, Microcirculation drug effects, Nicorandil administration & dosage, Papaverine administration & dosage, Vasodilator Agents administration & dosage
- Abstract
Background: Papaverine is used to induce maximal hyperemia for index of coronary microcirculatory resistance (IMR) measurement in animal experiments, although it can lead to polymorphic ventricular tachycardia and ventricular fibrillation., Objectives: This study investigated the effect of an intracoronary (IC) bolus of high adenosine triphosphate (ATP) and nicorandil doses for IMR measurement and explored the possibility of inducing maximal hyperemia with an IC alprostadil bolus., Material and Methods: Index of coronary microcirculatory resistance was measured in a hyperemic state induced by 7 experimental conditions in 21 pigs (IC bolus of papaverine (18 mg), ATP (40 μg, 80 μg, 160 μg, and 240 μg), and nicorandil (2 mg and 4 mg)). The 7 conditions were induced sequentially, and the average IMR was calculated. Because of the long-term hyperemic condition in the pilot experiments, the IMR was measured 1, 3, 5, 8, and 10 min after an IC bolus of alprostadil (10 μg) in another 7 pigs., Results: The IMR induced by 240 μg of ATP or 4 mg of nicorandil was not significantly different from that induced by 18 mg of papaverine (both p > 0.05). A strong linear correlation was observed between IMRs with papaverine (18 mg) and nicorandil (4 mg) (R2 = 0.936, p < 0.001) and with papaverine (18 mg) and ATP (240 μg) (R2 = 0.838, p < 0.05). The IC bolus of nicorandil (4 mg) produced the smallest changes, whereas papaverine caused the most significant changes in mean blood pressure and heart rate (p < 0.05). Tachypnea and transient ST depression were more common with increasing ATP dosages (especially 240 μg). Alprostadil (5 min) yielded a significant hyperemic response but reduced baseline blood pressure by almost 40% for a long time., Conclusions: Intracoronary bolus administration of 4 mg of nicorandil was better than 18 mg of papaverine or 240 μg of ATP for induction of maximal hyperemia and IMR measurement in a pig model, whereas alprostadil was not suitable for IMR measurement.
- Published
- 2019
- Full Text
- View/download PDF
33. RACK1 silencing attenuates renal fibrosis by inhibiting TGF-β signaling.
- Author
-
Feng J, Xie L, Kong R, Zhang Y, Shi K, Lu W, and Jiang H
- Subjects
- Epithelial Cells metabolism, Epithelial Cells pathology, Fibrosis pathology, Gene Expression Regulation, Humans, Kidney Diseases genetics, Kidney Diseases pathology, Kidney Tubules, Proximal metabolism, Kidney Tubules, Proximal pathology, Phosphorylation, Signal Transduction genetics, Fibrosis genetics, Receptors for Activated C Kinase genetics, Smad3 Protein genetics, Transforming Growth Factor beta1 genetics
- Abstract
The receptor for activated C-kinase 1 (RACK1) is a member of the WD40-repeat family of proteins and has been reported to be implicated in the development of liver fibrosis. However, the role of RACK1 in renal fibrosis remains unclear. Therefore, in this study, we investigated the effects of RACK1 on transforming growth factor-β1 (TGF-β1)-treated human proximal tubular epithelial cells and aimed to elucidate the possible mechanisms responsible for its anti-fibrotic effects. Our results revealed that RACK1 was highly expressed in the renal fibrotic tissues and TGF-β1-treated HK-2 cells. RACK1 silencing inhibited TGF-β1‑induced α-smooth muscle actin and connective tissue growth factor expression in the HK-2 cells. Furthermore, RACK1 silencing inhibited the expression of phosphorylated Smad3 in the TGF-β1-treated HK-2 cells. To the best of our knowledge, these data demonstrate for the first time the role of RACK1 in renal fibrosis. The present findings indicate that RACK1 silencing attenuates renal fibrosis by suppressing the activation of TGF-β1/Smad3 signaling pathway in HK-2 cells. Thus, RACK1 may serve as a novel regulator of renal fibrosis.
- Published
- 2017
- Full Text
- View/download PDF
34. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
- Author
-
Kong R, Liu W, Guo Y, Feng J, Cheng C, Zhang X, Ma Y, Li S, Jiang J, Zhang J, Qiao Z, Qin J, Lu T, and He X
- Subjects
- Carcinoma, Non-Small-Cell Lung pathology, Cell Line, Tumor, Cell Movement genetics, Cyclin D1 genetics, Cyclin-Dependent Kinase 4 genetics, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Carcinoma, Non-Small-Cell Lung genetics, Cell Proliferation genetics, MicroRNAs genetics, Nuclear Proteins genetics, RNA-Binding Proteins genetics
- Abstract
MicroRNAs (miRNAs) play critical roles in the development and progression of various cancers, including non-small-cell lung cancer (NSCLC). Studies have suggested that miR-330-5p is involved in the progression of several cancers. However, the role of miR-330-5p in NSCLC remains unclear. We investigated the effect on and mechanism of miR-330-5p in the progression of NSCLC. We found that miR-330-5p was significantly downregulated in NSCLC tissues and cell lines as detected by real-time quantitative polymerase chain reaction (RT-qPCR). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), bromodeoxyuridine (BrdU), colony formation and cell cycle assays showed that overexpression of miR-330-5p markedly inhibited cell growth. Annexin V-FITC/PI and caspase-3 activity assays showed that overexpression of miR-330-5p significantly promoted cell apoptosis of NSCLC cells. Bioinformatics analysis and dual-luciferase reporter assays confirmed NIN/RPN12 binding protein 1 (NOB1) as a target gene of miR-330-5p. RT-qPCR and Western blot analysis showed that overexpression of miR-330-5p inhibited the expression of NOB1 as well as cyclin D1 and cyclin-dependent kinase 4 in NSCLC cells. Moreover, overexpression of NOB1 markedly reversed the miR‑330-5p-mediated inhibitory effect on NSCLC cell growth. Correlation analysis showed that miR‑330-5p expression was inversely correlated with NOB1 mRNA expression in NSCLC tissues. Taken together, our results indicate that miR-330-5p inhibits NSCLC cell growth through downregulation of NOB1 expression. Our study suggests that miR-330-5p may serve as a potential therapeutic target for the treatment of NSCLC.
- Published
- 2017
- Full Text
- View/download PDF
35. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.
- Author
-
Ma Z, Feng J, Guo Y, Kong R, Ma Y, Sun L, Yang X, Zhou B, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Cheng Y, Zha D, and Liu S
- Subjects
- Animals, Cell Line, Tumor, Cell Movement, Cell Proliferation genetics, DEAD-box RNA Helicases metabolism, Epithelial-Mesenchymal Transition genetics, Female, Gene Expression Regulation, Neoplastic, Gene Knockdown Techniques, Humans, Mice, Inbred BALB C, Wnt Signaling Pathway genetics, Xenograft Model Antitumor Assays, beta Catenin genetics, beta Catenin metabolism, DEAD-box RNA Helicases genetics, Esophageal Neoplasms genetics, Esophageal Neoplasms pathology
- Abstract
DEAD (Asp-Glu-Ala-Asp) box protein 5 (DDX5), a prototypical member of the DEAD/H-box protein family, has been involved in several human malignancies. However, the expression and biological role of DDX5 in esophageal cancer (EC) remain largely unknown. In this study, we examined the role of DDX5 in regulating EC cell proliferation and tumorigenesis and explored its possible molecular mechanism. We found that DDX5 was overexpressed in human EC cell lines. In addition, knockdown of DDX5 significantly inhibited the proliferation of EC cells in vitro and the growth of EC xenografts in vivo. Knockdown of DDX5 also suppressed the migration/invasion and epithelial-to-mesenchymal transition (EMT) phenotype in EC cells. Furthermore, we observed that knockdown of DDX5 inhibited the expression of β-catenin, c-Myc, and cyclin D1 in EC cells. In conclusion, our findings provide the first evidence that siRNA-DDX5 inhibited the proliferation and invasion of EC cells through suppressing the Wnt/β-catenin signaling pathway. Therefore, DDX5 may be a novel potential therapeutic target for the prevention and treatment of EC.
- Published
- 2017
- Full Text
- View/download PDF
36. The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A.
- Author
-
Kong R, Ma Y, Feng J, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Yang X, and Zhou B
- Subjects
- Animals, Disease Progression, Esophageal Neoplasms pathology, Gene Expression Regulation, Neoplastic, Humans, Mice, Mice, Nude, MicroRNAs metabolism, Vascular Endothelial Growth Factor A genetics, Xenograft Model Antitumor Assays, Esophageal Neoplasms metabolism, Genes, Tumor Suppressor, MicroRNAs genetics, Vascular Endothelial Growth Factor A metabolism
- Abstract
Background: miR-126 is a key regulator of oncogenic processes. It is functionally linked to cellular proliferation, survival and migration. Vascular endothelial growth factor A (VEGF-A), which is regarded as a tumorgenesis activator, could directly target miR-126 in several tumors. However, the mechanism in esophageal cancer remains unclear., Methods and Results: In this study, the expression of miR-126 and VEGF-A were assessed in esophageal cancer tissues and esophageal cancer cell lines. We found that miR-126 has significantly lower expression in esophageal cancer tissues and esophageal cancer cell lines than in healthy tissues, while the expression of VEGF-A is high. Luciferase reporter assays were performed to investigate the relationship between VEGF-A and miR-126. We confirmed that VEGF-A is a target for miR-126. Furthermore, the proliferation of esophageal cancer cells with miR-126 overexpression and miR-126 knockdown was monitored using the MTT assay. The results showed that miR-126 could inhibit esophageal cancer cell proliferation in vitro. The effect of miR-126 was also detected in BALB/c nude mice with transplanted esophageal cancer cells. In vivo study showed that tumor growth was significantly suppressed by miR-126 overexpression., Conclusions: We believe that restoring miR-126 levels may be a promising therapeutic approach in cases of esophageal cancer.
- Published
- 2016
- Full Text
- View/download PDF
37. Downregulation of O-linked N-acetylglucosamine transferase by RNA interference decreases MMP9 expression in human esophageal cancer cells.
- Author
-
Qiao Z, Dang C, Zhou B, Li S, Zhang W, Jiang J, Zhang J, Ma Y, Kong R, and Ma Z
- Abstract
O-linked N-acetylglucosamine transferase (OGT) catalyzes O-linked glycosylation (O-GlcNAcylation). O-GlcNAcylation is a post-translational carbohydrate modification of diverse nuclear and cytosolic proteins by the addition of O-linked β-N-acetylglucosamine. It was recently demonstrated that OGT and the level of O-GlcNAcylation are upregulated in esophageal cancer; however, the physiological consequences of this upregulation remain unknown. The current study reports that OGT knockdown by short hairpin RNA (shRNA) did not affect cell viability; however, cell migration in esophageal cancer Eca-109 cells was significantly reduced. OGT-specific shRNA vectors efficiently decreased the protein and mRNA levels of OGT and the RL2 level (a marker of O-GlcNAcylation levels) in Eca-109 esophageal cancer cells. In addition, colony formation and cell proliferation assays demonstrated that OGT-specific shRNA decreased the proliferation of Eca-109 cells; however, there was no significant statistical difference between OGT-specific shRNA and control shRNA. Notably, transwell assays demonstrated that the migratory ability of Eca-109 cells was significantly suppressed following knockdown of the OGT gene. Correspondingly, western blot analyses demonstrated that OGT knockdown significantly downregulated the expression of matrix metalloproteinase 9 (MMP9) in Eca-109 cells. These results suggest that OGT may promote the migration, invasion and metastasis of esophageal cancer cells by enhancing the stability or expression of MMP9.
- Published
- 2016
- Full Text
- View/download PDF
38. Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway.
- Author
-
Kong R, Feng J, Ma Y, Zhou B, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Zhang T, Zang Q, and He X
- Subjects
- Animals, Carcinoma, Non-Small-Cell Lung metabolism, Cell Line, Tumor, Cell Proliferation, Female, Gene Expression Regulation, Neoplastic, Humans, Intracellular Signaling Peptides and Proteins, Lung Neoplasms metabolism, Male, Mice, Neoplasm Transplantation, Prognosis, Signal Transduction, Carcinogenesis metabolism, Carcinoma, Non-Small-Cell Lung pathology, Carrier Proteins metabolism, Lung Neoplasms pathology, Receptor, Notch1 metabolism
- Abstract
Non-small cell lung cancer (NSCLC) is the most common type of lung tumor with poor prognosis, in which the Notch signaling pathway plays an important role. Notch activation complex kinase (NACK) has been reported both as a co-activator and a target gene of the Notch pathway. However, the molecular mechanism of NACK in NSCLC still remains unknown. In this study, the expression of NACK was analyzed in 35 paired NSCLC tumor samples and 2 NSCLC cell lines. MTT assay, cell migration assay, cell invasion assay, flow cytometry assay, and xenograft model were employed to detect the effect of NACK knockdown on the cell proliferation, metastasis, invasion and apoptosis of NSCLC. The relationship between NACK and Notch1 signaling pathway in NSCLC cells was assessed by western blot and luciferase reporter assay. We found that the expression of NACK in the NSCLC tissues and lung cancer cells were significantly increased. High level of NACK expression is remarkable associated with tumor differentiation, lymphatic metastasis, clinical stage and poor survival prognosis. The interference of NACK significantly inhibited cell proliferation, invasion and metastasis through inducing apoptosis in NSCLC cells. The transcriptional activity of related Notch1 target genes were significantly suppressed resulting from NACK knockdown. This study demonstrates that interference of NACK inhibits NSCLC progression through Notch1 signaling pathway and targeting NACK may be an effective approach for NSCLC therapy.
- Published
- 2016
- Full Text
- View/download PDF
39. miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and p53 Expression in Hypoxic NSCLC Cells.
- Author
-
Ma Y, Feng J, Xing X, Zhou B, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Sun L, Ma Z, and Kong R
- Subjects
- A549 Cells, Adaptor Proteins, Signal Transducing genetics, Apoptosis genetics, Cell Line, Tumor, Down-Regulation genetics, Gene Expression Regulation, Neoplastic genetics, Humans, Transfection methods, Carcinoma, Non-Small-Cell Lung genetics, Cell Proliferation genetics, Hypoxia genetics, Lung Neoplasms genetics, MicroRNAs genetics, Proto-Oncogene Proteins c-akt genetics, Tumor Suppressor Protein p53 genetics
- Abstract
The ribosomal protein (RP)-p53 pathway has been shown to play a key role in apoptosis and senescence of cancer cells. miR-1908 is a newly found miRNA that was reported to have prognostic potential in melanoma. However, its role and mechanism in the progression of non-small cell lung cancer (NSCLC) are largely unknown. In this study, we found that expression of miR-1908 was significantly downregulated in human NSCLC cell lines, including SK-MES-1, A549, and NCI-H460. Then the role of miR-1908 in NSCLC cell proliferation was explored. The miR-1908 mimic was transfected into NSCLC cell lines, and their proliferation was detected. MTT and Cell Titer-Blue H analyses showed that the cell proliferation was notably reduced by the miR-1908 mimic transfection. Moreover, we found the RP-p53 pathway was activated by miR-1908 mimic. Moreover, the miR-1908 inhibitor transfection had a completely opposite effect on the NSCLC cell proliferation than that of miR-1908 mimic. To explore the underlying mechanism of that, TargetScan bioinformatics server and 3'-UTR luciferase reporter assay were applied to identify the targets of miR-1908. Our results showed that AKT1 substrate 1 (AKT1S1), a newly proven suppressor of the RP-p53 pathway, was a target of miR-1908, suggesting a probable mechanism for miR-191 suppressing NSCLC cell proliferation. Our findings provide a novel molecular target for the regulation of NSCLC cell proliferation.
- Published
- 2016
- Full Text
- View/download PDF
40. MicroRNA‑361‑5p suppresses cancer progression by targeting signal transducer and activator of transcription 6 in non‑small cell lung cancer.
- Author
-
Ma Y, Bao C, Kong R, Xing X, Zhang Y, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Zhang D, Ma Z, Sun L, and Zhou B
- Subjects
- Animals, Carcinoma, Non-Small-Cell Lung pathology, Cell Line, Tumor, Down-Regulation, Female, Humans, Lung metabolism, Lung Neoplasms pathology, Mice, Nude, Carcinoma, Non-Small-Cell Lung genetics, Gene Expression Regulation, Neoplastic, Lung pathology, Lung Neoplasms genetics, MicroRNAs genetics, STAT6 Transcription Factor genetics
- Abstract
The incidence of non‑small cell lung cancer (NSCLC) has significantly increased in China, while the prognosis of affected patients is poor. The pathogenesis of NSCLC is thought to be regulated by microRNAs (miRs). The present study used a miR array in order to determine the expression of miR‑361‑5p, which was significantly lower in NSCLC tissues compared with that in adjacent tissues, indicating a crucial role of miR‑361‑5p during the progression of NSCLC. Furthermore, the effects of transfection-induced upregulation of miR‑361‑5p on the NSCLC cell line H23 were assessed. Overexpression of miR‑361‑5p inhibited the proliferation and colony formation ability of H23 cells. In addition, apoptosis of H23 cells was induced by upregulation of miR‑361‑5p. Furthermore, signal transducer and activator of transcription 6 (STAT6) was confirmed as a direct target of miR‑361‑5p by a dual‑luciferase reporter assay. Moreover, inhibition of STAT6 by small interfering RNA or miR‑361‑5p also decreased the expression of B-cell lymphoma extra large (Bcl-xL). In vivo, miR‑361‑5p significantly reduced tumor growth in a nude mouse xenograft model, and suppressed STAT6 and Bcl-xL expression. In conclusion, the present study indicated that miR‑361‑5p may represent a novel molecular tool for therapeutic and diagnostic strategies in NSCLC.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.